Caixin China Biz Roundup: Chinese mRNA Jab Activates 80% to 95% Immune Response

Jan.26.2022

Behind the findings of the homegrown shot’s first stage clinical trials; Beijing’s plan to stay smog-free over the Olympics; and China digests a record amount of bad assets

00:00

00:00/00:00

Contact senior podcast producer Nandini Venkata （nandinivenkata@caixin.com）

Download our app to receive breaking news alerts and read the news on the go.

Get our weekly free Must-Read newsletter.

Share this article

Open WeChat and scan the QR code

MORE WAYS TO LISTEN